Latest

A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆

Markets · 15 min delay

NBI4,187.6▲ +1.14%

PFE28.42▼ -0.38%

AZN74.18▲ +0.81%

NVO103.55▲ +2.07%

ROG261.40▼ -0.55%

ABBV174.92▲ +0.29%

EUR/USD1.0842▼ -0.12%

ISEQ9,241.3▲ +0.62%

NBI4,187.6▲ +1.14%

PFE28.42▼ -0.38%

AZN74.18▲ +0.81%

NVO103.55▲ +2.07%

ROG261.40▼ -0.55%

ABBV174.92▲ +0.29%

EUR/USD1.0842▼ -0.12%

Updated 04 Jul 2026 · HPRA open data

Camurus AB — Licensed Medicines

9 medicines held by Camurus AB on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

← All medicines · 9 products held by Camurus AB

Medicine	Active substance	Licence holder	Status
Buvidal 128 mg Prolonged-release solution for injection EU/1/18/1336/007	Buprenorphine	Camurus AB	—
Buvidal 16 mg Prolonged-release solution for injection EU/1/18/1336/002	Buprenorphine	Camurus AB	—
Buvidal 160 mg Prolonged-release solution for injection EU/1/18/1336/009	Buprenorphine	Camurus AB	—
Buvidal 24 mg Prolonged-release solution for injection EU/1/18/1336/003	Buprenorphine	Camurus AB	—
Buvidal 32 mg Prolonged-release solution for injection EU/1/18/1336/004	Buprenorphine	Camurus AB	—
Buvidal 64 mg Prolonged-release solution for injection EU/1/18/1336/005	Buprenorphine	Camurus AB	—
Buvidal 8 mg Prolonged-release solution for injection EU/1/18/1336/001	Buprenorphine	Camurus AB	—
Buvidal 96 mg Prolonged-release solution for injection EU/1/18/1336/006	Buprenorphine	Camurus AB	—
Oczyesa 20 mg prolonged-release solution for injection in pre-filled pen EU/1/25/1938/001	Octreotide hydrochloride	Camurus AB	—

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.